OpenVSafe by OpenVAERS
Search V-safe

Z6Y-12564-74320

2 vaccinations 9 coded responses 9 check-ins 9 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
336 / FL
Registered
2021-04-29
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-02
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-23
    Dose 2 — Pfizer-BioNTech
  3. 2021-04-29
    Registered in v-safe
  4. 2021-04-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough, Dyspnoea — Feeling: Poor · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Shortness of breath and coughing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-30
    Survey response — day 7, dose 2
    MedDRA: Tachycardia — Feeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-07
    Survey response — day 14, dose 2
    MedDRA: Alanine aminotransferase increased, Anxiety, Asthenia, Blood pressure increased, Blood test abnormal, Cough, Dyspnoea, Fatigue, Hypertension, Rash, Tachycardia, Urticaria — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Large Hives and rash down L and R arms left leg and back that is getting worse Weakness Tachycardia Coughing Shortness of breath Fatigue Higher than normal BP Anxiety Elevated liver ALT in blood test
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-05-14
    Survey response — day 21, dose 2
    MedDRA: Fatigue, Neurological symptom, Urticaria — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Fatigue hives neurological symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-05-21
    Survey response — day 28, dose 2
    MedDRA: Cough, Dyspnoea, Fatigue, Nausea, Neuralgia, Urticaria — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Menstrual cycle 2xs since vaccine Nerve painNausea Hives Cough shortness of breath Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-28
    Survey response — day 35, dose 2
    MedDRA: Chest pain, Cough, Fatigue — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Chest pain Fatigue Cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-06-06
    Survey response — day 42, dose 2
    MedDRA: Chest pain, Dyspnoea, Fatigue — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Shortness of breath chest pain and fatigue neurological pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-07-23
    Survey response — 3 months, dose 2
    MedDRA: Chest pain, Emergency care — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: ER chest pain Dr gave referral to cardiologist
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  12. 2021-10-22
    Survey response — 6 months, dose 2
    MedDRA: Cough, Fatigue, Heart rate increased, Incontinence, Neurological symptom, Respiratory tract infection, White matter lesion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chronic cough respiratory infection Rapid heart rate Incontinence Fatigue Neurological symptoms White matter disease
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-02Pfizer-BioNTech
22021-04-23Pfizer-BioNTech

Free text

Release 8 — days 1–6 daily, dose 2

2021-04-29

Systemic reaction (other): Shortness of breath and coughing

Release 8 — day 7, dose 2

2021-04-30

Systemic reaction (other): Tachycardia

Release 8 — day 14, dose 2

2021-05-07

Symptoms: Large Hives and rash down L and R arms left leg and back that is getting worse Weakness Tachycardia Coughing Shortness of breath Fatigue Higher than normal BP Anxiety Elevated liver ALT in blood test

Release 8 — day 21, dose 2

2021-05-14

Symptoms: Fatigue hives neurological symptoms

Release 8 — day 28, dose 2

2021-05-21

Symptoms: Menstrual cycle 2xs since vaccine Nerve painNausea Hives Cough shortness of breath Fatigue

Release 8 — day 35, dose 2

2021-05-28

Symptoms: Chest pain Fatigue Cough

Release 8 — day 42, dose 2

2021-06-06

Symptoms: Shortness of breath chest pain and fatigue neurological pain

Release 9 — 3 months, dose 2

2021-07-23

Symptoms: ER chest pain Dr gave referral to cardiologist

Release 10 — 6 months, dose 2

2021-10-22

Symptoms: Chronic cough respiratory infection Rapid heart rate Incontinence Fatigue Neurological symptoms White matter disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAlanine aminotransferase increased ✓ ✓ ✓
SDAnxiety ✓ ✓ ✓
SDAsthenia ✓ ✓ ✓
SDBlood pressure increased ✓ · ✓
SDBlood test abnormal ✓ · ✓
SDChest pain ✓ ✓ ✓
SDCough ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDEmergency care ✓ · ✓
SDFatigue ✓ ✓ ✓
SDHeart rate increased · · ✓
SDHypertension ○ ✓ ○
SDIncontinence · · ✓
SDNausea ✓ ✓ ✓
SDNeuralgia ✓ ✓ ✓
SDNeurological symptom ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDRespiratory tract infection · · ✓
SDTachycardia ✓ ✓ ✓
SDUrticaria ✓ ✓ ✓
SDWhite matter lesion · · ✓
SROCough ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROTachycardia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…